These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 8769208)

  • 41. A meta-analysis to assess the safety and tolerability of two formulations of cyclosporine: Sandimmune and Neoral.
    Shah MB; Martin JE; Schroeder TJ; First MR
    Transplant Proc; 1998 Dec; 30(8):4048-53. PubMed ID: 9865291
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of renal transplant outcome with Neoral versus Sandimmune as part of an initial triple therapy regimen.
    alShaibani K; Raza S; alFurayh O; alMeshari K; alAhmadi I; alSabban E
    Transplant Proc; 1998 Nov; 30(7):3519-20. PubMed ID: 9838542
    [No Abstract]   [Full Text] [Related]  

  • 43. An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients.
    Park K; Koh YB; Kwak JY; Kim SJ; Yoon YS; Kang CM; Kim YS
    Transplant Proc; 1996 Jun; 28(3):1202-3. PubMed ID: 8658627
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunosuppressive therapy with microemulsion cyclosporine A shortens the hospitalization of pediatric liver transplant recipients.
    Arumugam R; Soriano HE; Scheimann AO; Reid BS; Gopalakrishna GS; Barakat O; Ozaki CF; Wood PR
    Clin Transplant; 1998 Dec; 12(6):588-92. PubMed ID: 9850457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
    Cantarovich M; Latter DA; Loertscher R
    Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefits of cyclosporine microemulsion (Neoral) C(2) monitoring are sustained at 1 year in de novo liver transplant recipients.
    Lake JR;
    Transplant Proc; 2001; 33(7-8):3092-3. PubMed ID: 11750328
    [No Abstract]   [Full Text] [Related]  

  • 47. Neoral as the initial immunosuppressant in liver transplantation; conversion from Sandimmune to Neoral in stable patients.
    Kizilisik AT; al-Sebayel M; Ramirez CB
    Transplant Proc; 1998 Nov; 30(7):3537-8. PubMed ID: 9838549
    [No Abstract]   [Full Text] [Related]  

  • 48. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclosporine pharmacokinetics in stable renal transplant patients: effect of formulation Sandimmun versus Consupren versus Neoral.
    Masri MA; Barbari A; Stephan A; Kamel G; Frem G; Younan F; Rizk S; Moubarak R; Karam A
    Transplant Proc; 1996 Jun; 28(3):1318-20. PubMed ID: 8658676
    [No Abstract]   [Full Text] [Related]  

  • 50. Neoral in liver transplantation.
    Levy GA; Grant D
    Transplant Proc; 1996 Apr; 28(2):1019-21. PubMed ID: 8623216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 52. Comparative efficacy of prophylactic monoclonal (OKT3) and polyclonal antibodies (ATG) in immunologic high-risk renal transplant recipients.
    Fukuuchi F; Lefrançois N; Chapuis F; Gebuhrer L; Bosshard S; Dubernard JM; Touraine JL
    Transplant Proc; 1996 Oct; 28(5):2808-9. PubMed ID: 8908070
    [No Abstract]   [Full Text] [Related]  

  • 53. Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients.
    Fisher RA; Pan SH; Rossi SJ; Schroeder TJ; Irish WD; Canafax DM; Lopez RR
    Transplant Proc; 1999; 31(1-2):394-5. PubMed ID: 10083157
    [No Abstract]   [Full Text] [Related]  

  • 54. Quadruple-drug therapy with antithymocyte globulin in the early postoperative period after liver transplantation.
    Schattenfroh N; Lange D; Bechstein WO; Blumhardt G; Lohmann R; Neuhaus P
    Transplant Proc; 1993 Apr; 25(2):1968-9. PubMed ID: 8470245
    [No Abstract]   [Full Text] [Related]  

  • 55. Incidence and patterns of rejection using different induction therapies in liver transplant recipients.
    Elkashab M; Reizig M; Greig PD; Cameron R; Phillips MJ; Chung S; Cattral M; Levy G
    Transplant Proc; 1994 Oct; 26(5):2669-71. PubMed ID: 7940835
    [No Abstract]   [Full Text] [Related]  

  • 56. Safety of conversion from cyclosporine Sandimmune to cyclosporine Neoral in stable liver transplant patients.
    Baruch Y; Assy N; Kramsky R; Enat R
    Transplant Proc; 1998 Aug; 30(5):1852-3. PubMed ID: 9723306
    [No Abstract]   [Full Text] [Related]  

  • 57. An open-label study of the safety and tolerability of converting stable liver transplant recipients to neoral.
    Pasha TM; Wiesner RH; Dahlke LM; Porayko MK; Krom RA
    Liver Transpl Surg; 1998 Sep; 4(5):410-5. PubMed ID: 9724479
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR; Platz KP; Krause P; Neuhaus R; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract]   [Full Text] [Related]  

  • 59. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
    Dunn SP; Falkenstein K; Pierson A; Cooney GF
    Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
    [No Abstract]   [Full Text] [Related]  

  • 60. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.